(Q34115719)

English

Decreased expression of BATF2 is associated with a poor prognosis in hepatocellular carcinoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Decreased expression of BATF2 is associated with a poor prognosis in hepatocellular carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

Haiqing Ma

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Xiaoting Liang

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Yibing Chen

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Ke Pan

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Jiancong Sun

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Hui Wang

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Qijing Wang

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Yongqiang Li

8

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Jingjing Zhao

9

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Jianjun Li

10

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Minshan Chen

11

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Jianchuan Xia

12

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

0 references

publication date

1 February 2011

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

128

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

771-777

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Biological treatment for liver tumor and new potential biomarkers.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25407

21 January 2018

Cloning and characterization of SARI (suppressor of AP-1, regulated by IFN).

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25407

21 January 2018

Assessment of antigen damage in immunohistochemistry. The vimentin internal control

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25407

21 January 2018

Tissue preparation for immunocytochemistry

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25407

21 January 2018

The prognostic molecular markers in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25407

21 January 2018

Molecular pathogenesis and targeted therapy of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25407

21 January 2018

Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25407

21 January 2018

Identifiers

10.1002/IJC.25407

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34115719&oldid=1539974242"